Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.32 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6722036 | 0.75 | MAPT (0.42) | MAPTGAAALDH1A1NPC1LMNA | |
| SCHEMBL6393954 | 0.72 | MAPT (0.34) | MAPTGAAALDH1A1NPC1LMNA | |
| SCHEMBL8515490 | 0.68 | CHRM2 (0.46) | MAPTALDH1A1CHRM2CHRM4CHRM5 | |
| SCHEMBL12700286 | 0.68 | CHRM2 (0.46) | MAPTALDH1A1CHRM2CHRM4CHRM5 | |
| SCHEMBL15095887 | 0.68 | CHRM2 (0.46) | MAPTALDH1A1CHRM2CHRM4CHRM5 | |
| SCHEMBL22788167 | 0.66 | — | — | |
| SCHEMBL12057880 | 0.64 | MAPT (0.35) | MAPTGAAALDH1A1NPC1LMNA | |
| SCHEMBL16689092 | 0.64 | — | — | |
| Propane SCHEMBL3777305 | 0.64 | CHRM2 (0.40) | MAPTALDH1A1CHRM2CHRM4CHRM5 | |
| SCHEMBL24752922 | 0.63 | CHRM2 (0.43) | MAPTCHRM2CHRM4CHRM5CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0792170-A4 | RADIONUCLIDE METAL CHELATES FOR THE RADIOLABELING OF LIGANDS, ANTI-LIGANDS OR OTHER PROTEINS | NEORX CORP (US) | 2000-03-15 | — | — | EP | disclosed |
| EP-0792170-A1 | RADIONUCLIDE METAL CHELATES FOR THE RADIOLABELING OF LIGANDS, ANTI-LIGANDS OR OTHER PROTEINS | NEORX CORPORATION (US) | 1997-09-03 | — | — | EP | disclosed |
| EP-0461245-A4 | RADIOLABELED PROTEINS FOR DIAGNOSTIC OR THERAPEUTIC USE | GUSTAVSON LINDA M (US) | 1994-10-05 | — | — | EP | disclosed |
| EP-0431146-A4 | RADIONUCLIDE METAL CHELATES FOR THE RADIOLABELING OF PROTEINS | — | 1992-11-04 | — | — | EP | disclosed |
| EP-0436664-A4 | CLEAVABLE LINKERS FOR THE REDUCTION OF NON-TARGET ORGAN RETENTION OF IMMUNOCONJUGATES | — | 1992-04-22 | — | — | EP | disclosed |
| EP-0461245-A1 | RADIOLABELED PROTEINS FOR DIAGNOSTIC OR THERAPEUTIC USE | NEORX CORPORATION (US) | 1991-12-18 | — | — | EP | disclosed |
| EP-0436664-A1 | CLEAVABLE LINKERS FOR THE REDUCTION OF NON-TARGET ORGAN RETENTION OF IMMUNOCONJUGATES. | NEORX CORP (US) | 1991-07-17 | — | — | EP | disclosed |
| WO-1991009876-A1 | RADIOLABELED PROTEINS FOR DIAGNOSTIC OR THERAPEUTIC USE | NEORX CORPORATION (US) | 1991-07-11 | — | — | WO | disclosed |
| EP-0431146-A1 | RADIONUCLIDE METAL CHELATES FOR THE RADIOLABELING OF PROTEINS. | NEORX CORP (US) | 1991-06-12 | — | — | EP | disclosed |
| WO-1990015808-A1 | RADIONUCLIDE METAL CHELATES FOR THE RADIOLABELING OF PROTEINS | NEORX CORPORATION (US) | 1990-12-27 | — | — | WO | disclosed |